Felipe D. A. D. L. F.
- Country
- Spain
- Department
- Servicio de Hematología
Research Overview
- Phase III Randomized Trial of Bortezomib, Melphalan, Prednisone, Lenalidomide, Dexamethasone, Carfilzomib, and Daratumumab in Elderly Patients with Newly Diagnosed Multiple Myeloma
- Phase II Multicenter Study of Carfilzomib, Lenalidomide, and Dexamethasone in High-Risk Smoldering Multiple Myeloma Patients ≤70 Years
- Efficacy and Safety Evaluation of Belantamab Mafodotin with Pomalidomide and Dexamethasone versus Pomalidomide, Bortezomib, and Dexamethasone in Relapsed/Refractory Multiple Myeloma
Data & Insights
Has run more than one trial at 149 of 300 partner sites.
Specializations
Multiple Myeloma Treatment
The investigator specializes in treating multiple myeloma, with particular expertise in managing both newly diagnosed cases and relapsed/refractory disease. Their research focuses on innovative therapeutic combinations for patients at various stages of the disease.
- Novel Drug Combinations
- Treatment-resistant Myeloma
- Early Disease Intervention
Extensive work in developing therapeutic strategies for patients who have exhausted standard treatment options.
Targeted Therapies
Leading investigations into monoclonal antibody treatments and their combinations with established therapies. Special focus on immunotherapy approaches and targeted molecular treatments for hematologic malignancies.
- Antibody-based Treatments
- Combination Therapy Development
- Immunotherapy Innovation
Pioneering work in integrating novel therapeutic agents with existing treatment protocols.
Early Disease Management
Expertise in treating high-risk monoclonal gammopathy and smoldering multiple myeloma. Focus on early intervention strategies and preventive approaches for disease progression.
- Preventive Treatment Strategies
- Risk Assessment Protocols
- Disease Progression Management
Development of therapeutic approaches for early-stage plasma cell disorders and high-risk patient populations.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.